ODYSSEY_HCM: A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Sep 19, 2026 - P3 | N=580 | Terminated | Sponsor: Bristol-Myers Squibb | Completed ➔ Terminated; Trial terminated because of lack of efficacy in the short term acute phase
Trial termination • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Non-obstructive Hypertrophic Cardiomyopathy
|